North America CIN & HR-HPV Treatment Market

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America CIN & HR-HPV Market – by Disease Type

1.3.2 North America CIN & HR-HPV Market – by Strain Type

1.3.3 North America CIN & HR-HPV Market – by Offering

1.3.4 North America CIN & HR-HPV Market – by Product Type

1.3.5 North America CIN & HR-HPV Market – by End User

1.3.6 North America CIN & HR-HPV Market – by Country

2. North America CIN & HR-HPV Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America CIN & HR-HPV Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.3 Expert’s Opinion

5. North America CIN & HR-HPV Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Human Papillomavirus Infections

5.1.2 Favourable Initiatives for Preventing Cervical Cancer

5.2 Market Restraints

5.2.1 Increased Reoccurrence Rate and High Cost of CIN & HR-HPV Treatment

5.3 Market Opportunities

5.3.1 Development and Launch of Innovative Products

5.4 Future Trends

5.4.1 Use of Modern Technologies in CIN & HR-HPV Screening and Diagnosis

5.5 Impact Analysis

6. CIN & HR-HPV Market – North America Analysis

6.1 North America CIN & HR-HPV Market Revenue Forecast and Analysis

7. North America CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028– by Disease Type

7.1 Overview

7.2 North America CIN and HR-HPV Treatment Market, By disease type, 2022 & 2028 (%)

7.3 CIN 1

7.3.1 Overview

7.3.2 CIN 1: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

7.4 CIN 2

7.4.1 Overview

7.4.2 CIN 2: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

7.5 CIN 3

7.5.1 Overview

7.5.2 CIN 3: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8. North America CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028– by Strain Type

8.1 Overview

8.2 HPV 16

8.2.1 Overview

8.2.2 HPV 16: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.3 HPV 18

8.3.1 Overview

8.3.2 HPV 18: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

8.4 Others

8.4.1 Overview

8.4.2 Others: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9. North America CIN and HR-HPV Treatment Market Revenue and Forecasts To 2028– by Offering

9.1 Overview

9.2 North America CIN and HR-HPV Treatment Market, By Offering, 2022 & 2028 (%)

9.4 Diagnostic Method

9.4.1 Overview

9.4.2 Diagnostic Method: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4.3 Pap Smear

9.4.3.1 Overview

9.4.3.2 Pap Smear: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4.4 HPV Testing

9.4.4.1 Overview

9.4.4.2 HPV Testing: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4.5 Colposcopy

9.4.5.1 Overview

9.4.5.2 Colposcopy: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.4.6 Biopsy

9.4.6.1 Overview

9.4.6.2 Biopsy: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.5 Treatment

9.5.1 Overview

9.5.2 Treatment: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.5.2.1 Excision Surgery

9.5.2.1.1 Overview

9.5.2.1.2 Excision Surgery: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

9.5.2.2 Ablation Techniques

9.5.2.2.1 Overview

9.5.2.2.2 Ablation Techniques: CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

10. North America CIN & HR-HPV Treatment Market Analysis and Forecast to 2028 – by Product Type

10.1 Overview

10.2 North America CIN & HR-HPV Treatment Market, by Product Type 2022 & 2028 (%)

10.3 Kits & Reagents

10.3.1 Overview

10.3.2 Kits & Reagents: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Instrument

10.4.1 Overview

10.4.2 Instrument: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Services

10.5.1 Overview

10.5.2 Services: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11. North America CIN & HR-HPV Treatment Market Analysis and Forecast to 2028 – by End User

11.1 Overview

11.2 North America CIN & HR-HPV Treatment Market, by End User 2022 & 2028 (%)

11.3 Hospital & Clinics

11.3.1 Overview

11.3.2 Hospital & Clinics: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.4 Diagnostic Laboratories

11.4.1 Overview

11.4.2 Diagnostic Laboratories: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.5 Specialized Clinical Laboratories

11.5.1 Overview

11.5.2 Specialized Clinical Laboratories: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

11.6 Others

11.6.1 Overview

11.6.2 Others: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12. CIN & HR-HPV Treatment Market Revenue and Forecasts to 2028 – Country Analysis

12.1 North America: CIN & HR-HPV Treatment Market

12.1.1 Overview

12.1.2 North America: CIN & HR-HPV Treatment Market, by Country, 2022 & 2028 (%)

12.1.2.1 US: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.1 Overview

12.1.2.1.2 US: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.1.3 US: CIN & HR-HPV Treatment Market, by Disease Type, 2019–2028 (US$ Million)

12.1.2.1.4 US: CIN & HR-HPV Treatment Market, by Strain Type, 2019–2028 (US$ Million)

12.1.2.1.5 US: CIN & HR-HPV Treatment Market, by Offerings, 2019–2028 (US$ Million)

12.1.2.1.5.1 US: CIN & HR-HPV Treatment Market, by Diagnostic Methods, 2019–2028 (US$ Million)

12.1.2.1.5.2 US: CIN & HR-HPV Treatment Market, by Treatments, 2019–2028 (US$ Million)

12.1.2.1.6 US: CIN & HR-HPV Treatment Market, by Product Type, 2019–2028 (US$ Million)

12.1.2.1.7 US: CIN & HR-HPV Treatment Market, by End Users, 2019–2028 (US$ Million)

12.1.2.2 Canada: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.1 Overview

12.1.2.2.2 Canada: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.2.3 Canada: CIN & HR-HPV Treatment Market, by Type, 2019–2028 (US$ Million)

12.1.2.2.4 Canada: CIN & HR-HPV Treatment Market, by Strain Type, 2019–2028 (US$ Million)

12.1.2.2.5 Canada: CIN & HR-HPV Treatment Market, by Offerings , 2019–2028 (US$ Million)

12.1.2.2.5.1 Canada: CIN & HR-HPV Treatment Market, by Diagnostic Methods, 2019–2028 (US$ Million)

12.1.2.2.5.2 Canada: CIN & HR-HPV Treatment Market, by Treatments, 2019–2028 (US$ Million)

12.1.2.2.6 Canada: CIN & HR-HPV Treatment Market, by Product Type, 2019–2028 (US$ Million)

12.1.2.2.7 Canada: CIN & HR-HPV Treatment Market, by End Users, 2019–2028 (US$ Million)

12.1.2.3 Mexico: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.1 Overview

12.1.2.3.2 Mexico: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.2.3.3 Mexico: CIN & HR-HPV Treatment Market, by Disease Type, 2019–2028 (US$ Million)

12.1.2.3.4 Mexico: CIN & HR-HPV Treatment Market, by Strain Type, 2019–2028 (US$ Million)

12.1.2.3.5 Mexico: CIN & HR-HPV Treatment Market, by Offerings, 2019–2028 (US$ Million)

12.1.2.3.5.1 Mexico: CIN & HR-HPV Treatment Market, by Diagnostic Methods, 2019–2028 (US$ Million)

12.1.2.3.5.2 Mexico: CIN & HR-HPV Treatment Market, by Treatments, 2019–2028 (US$ Million)

12.1.2.3.6 Mexico: CIN & HR-HPV Treatment Market, by Product Type, 2019–2028 (US$ Million)

12.1.2.3.7 Mexico: CIN & HR-HPV Treatment Market, by End Users, 2019–2028 (US$ Million)

13. North America CIN & HR-HPV Treatment Market – Industry Landscape

13.1 Overview

13.2 Growth Strategies in CIN & HR-HPV Treatment Market

13.3 Organic Growth Strategies

13.3.1 Overview

13.4 Inorganic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Fujirebio Europe NV

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Qiagen NV

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Abbott Laboratories

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Cepheid

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 F. Hoffmann-La Roche Ltd

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 INOVIO Pharmaceuticals Inc

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Bioneer Corp

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Antiva Biosciences Inc

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Thermo Fisher Scientific Inc

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. US CIN & HR-HPV Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 2. US: CIN & HR-HPV Treatment Market, by Strain Type – Revenue and Forecast to 2028 (US$ Million)

Table 3. US CIN & HR-HPV Treatment Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)

Table 4. US: CIN & HR-HPV Treatment Market, by Diagnostic Methods – Revenue and Forecast to 2028 (US$ Million)

Table 5. US: CIN & HR-HPV Treatment Market, by Treatments – Revenue and Forecast to 2028 (US$ Million)

Table 6. US CIN & HR-HPV Treatment Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 7. US: CIN & HR-HPV Treatment Market, by End Users – Revenue and Forecast to 2028 (US$ Million)

Table 8. Canada: CIN & HR-HPV Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. Canada CIN & HR-HPV Treatment Market, by Strain Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. Canada CIN & HR-HPV Treatment Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)

Table 11. Canada CIN & HR-HPV Treatment Market, by Diagnostic Methods – Revenue and Forecast to 2028 (US$ Million)

Table 12. Canada CIN & HR-HPV Treatment Market, by Treatments – Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada CIN & HR-HPV Treatment Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada CIN & HR-HPV Treatment Market, by End Users – Revenue and Forecast to 2028 (US$ Million)

Table 15. Mexico: CIN & HR-HPV Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 16. Mexico CIN & HR-HPV Treatment Market, by Strain Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Mexico: CIN & HR-HPV Treatment Market, by Offerings – Revenue and Forecast to 2028 (US$ Million)

Table 18. Mexico CIN & HR-HPV Treatment Market, by Diagnostic Methods – Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico: CIN & HR-HPV Treatment Market, by Treatments – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico CIN & HR-HPV Treatment Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 21. Mexico: CIN & HR-HPV Treatment Market, by End Users – Revenue and Forecast to 2028 (US$ Million)

Table 22. Recent Organic Growth Strategies in CIN & HR-HPV Treatment Market

Table 23. Recent Inorganic Growth Strategies in the CIN & HR-HPV Treatment Market

Table 24. Glossary of Terms

LIST OF FIGURES

Figure 1. North America CIN & HR-HPV Market Segmentation

Figure 2. North America CIN & HR-HPV Market, by Country

Figure 3. North America CIN & HR-HPV Market Overview

Figure 4. Cervical Intraepithelial Neoplasia 3 Segment Held Largest Share of Disease Type Segment in CIN & HR-HPV Market

Figure 5. The US Expected to Show Remarkable Growth During Forecast Period

Figure 6. North America: PEST Analysis

Figure 7. North America Experts’ Opinion

Figure 8. CIN & HR-HPV Market: Impact Analysis of Drivers and Restraints

Figure 9. North America CIN & HR-HPV Market – Revenue Forecast and Analysis – 2020–2028

Figure 10. North America CIN and HR-HPV Treatment Market, by disease type, 2022 & 2028 (%)

Figure 11. CIN 1: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. CIN 2: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. CIN 3: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. North America CIN and HR-HPV Treatment Market, by Strain Type, 2022 & 2028 (%)

Figure 15. HPV 16: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. HPV 18: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Others: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. North America CIN and HR-HPV Treatment Market, by offering, 2022 & 2028 (%)

Figure 19. Diagnostic Method: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Pap Smear: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. HPV Testing: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Colposcopy: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Biopsy: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Treatment: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. Excision Surgery: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. Ablation Techniques: North America CIN and HR-HPV Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. North America CIN & HR-HPV Treatment Market, by Product Type 2022 & 2028 (%)

Figure 28. Kits & Reagents: North America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Instrument: North America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Services: North America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. North America CIN & HR-HPV Treatment Market, by End User 2022 & 2028 (%)

Figure 32. Hospital & Clinics: North America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Diagnostic Laboratories: North America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34. Specialized Clinical Laboratories: North America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35. Others: North America CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36. North America: CIN & HR-HPV Treatment Market, by Key Country – Revenue (2022) (US$ Million)

Figure 37. North America: CIN & HR-HPV Treatment Market, by Country, 2022 & 2028 (%)

Figure 38. US: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39. Canada: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40. Mexico: CIN & HR-HPV Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41. Growth Strategies in CIN & HR-HPV Treatment Market